ZJZhou Jiang

Zhou Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhou Jiang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Meng Zhang

    Affiliation Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu, China

    1 shared publication
  • Ping Zeng

    Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, China

    1 shared publication
  • Shuiping Huang

    Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, China

    1 shared publication
  • Ting Wang

    Affiliation Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu, China

    1 shared publication
  • Zhonghe Shao

    Affiliation Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu, China

    1 shared publication

Latest Publications

  • Open Access

    IUSMMT: Survival mediation analysis of gene expression with multiple DNA methylation exposures and its application to cancers of TCGA

    by Zhonghe Shao, Ting Wang, Meng Zhang, Zhou Jiang, Shuiping Huang, Ping Zeng

    Effective and powerful survival mediation models are currently lacking. To partly fill such knowledge gap, we particularly focus on the mediation analysis that includes multiple DNA methylations acting as exposures, one gene expression as the mediator and one survival time as the outcome. We proposed IUSMMT (intersection-union survival mixture-adjusted mediation test) to effectively examine the existence of mediation effect by fitting an empirical three-component mixture null distribution. With extensive simulation studies, we demonstrated the advantage of IUSMMT over existing methods. We applied IUSMMT to ten TCGA cancers and identified multiple genes that exhibited mediating effects. We further revealed that most of the identified regions, in which genes behaved as active mediators, were cancer type-specific and exhibited a full mediation from DNA methylation CpG sites to the survival risk of various types of cancers. Overall, IUSMMT represents an effective and powerful alternative for survival mediation analysis; our results also provide new insights into the functional role of DNA methylation and gene expression in cancer progression/prognosis and demonstrate potential therapeutic targets for future clinical practice.